Adventures in Drug Discovery: Building a Better Anti-Inflammatory Drug

John Wallace PhD, MBA, FRSC
Chief Scientific Officer, Antibe Therapeutics Inc | Adjunct Professor, Pharmacology & Toxicology, University of Toronto
Tuesday, February 19, 2019 - 4:00pm
MSB 4171
Departmental Seminar
Host: 
Leonardo Salmena, Ph.D., Department of Pharmacology and Toxicology
Pharmacology and Toxicology Seminar
Poster: